Home > Riviste > European Journal of Physical and Rehabilitation Medicine > Fascicoli precedenti > European Journal of Physical and Rehabilitation Medicine 2013 Febbraio;49(1) > European Journal of Physical and Rehabilitation Medicine 2013 Febbraio;49(1):119-30

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE

Rivista di Medicina Fisica e Riabilitativa dopo Eventi Patologici


Official Journal of the Italian Society of Physical and Rehabilitation Medicine (SIMFER), European Society of Physical and Rehabilitation Medicine (ESPRM), European Union of Medical Specialists - Physical and Rehabilitation Medicine Section (UEMS-PRM), Mediterranean Forum of Physical and Rehabilitation Medicine (MFPRM), Hellenic Society of Physical and Rehabilitation Medicine (EEFIAP)
In association with International Society of Physical and Rehabilitation Medicine (ISPRM)
Indexed/Abstracted in: CINAHL, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,063


eTOC

 

REVIEWS  


European Journal of Physical and Rehabilitation Medicine 2013 Febbraio;49(1):119-30

lingua: Inglese

Sarcopenia or muscle modifications in neurologic diseases: a lexical or patophysiological difference?

Carda S. 1, Cisari C. 2, 3, Invernizzi M. 2, 3

1 Unit of Neuropsychology and Neurorehabilitation, Lausanne University Hospital (CHUV), Lausanne, Switzerland;
2 Unit of Physical and Rehabilitation Medicine, Department of Health Sciences, “A. Avogadro” Piemonte Orientale University, Novara, Italy;
3 Società Italiana per lo Studio delle Disabilità , Muscolo-Scheletriche, S.I.S.D.I.M, Rome, Italy


FULL TEXT  


Sarcopenia is a condition characterized by a decrease in muscle mass and function (strength and mobility) that is frequently observed in the elderly. In people with paresis and altered mobility due to central nervous system (CNS) diseases, this definition then may not be applicable. In CNS diseases, mainly stroke and spinal cord injury, different and specific patterns of muscle loss and muscle changes have been described, due to denervation, disuse atrophy, spasticity and myosteatosis. The main observations available about these phenomena in CNS diseases are reviewed, and a broad view on the specific physiopathological mechanisms is also described. Moreover, a description of the potential pharmacological targets and treatment strategies (physical and nutritional) is provided. Since sarcopenia of the elderly and muscle modifications and muscle atrophy in CNS diseases have different mechanisms, it is probable that they do not respond equally to the same treatments.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

stefano.carda@chuv.ch